Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$3.27 - $8.76 $724,017 - $1.94 Million
-221,412 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$7.56 - $14.3 $148,924 - $281,695
19,699 Added 9.77%
221,412 $1.81 Million
Q4 2021

Feb 14, 2022

BUY
$12.24 - $21.25 $500,273 - $868,530
40,872 Added 25.41%
201,713 $2.88 Million
Q3 2021

Nov 15, 2021

BUY
$16.69 - $26.05 $2.68 Million - $4.19 Million
160,841 New
160,841 $3.1 Million
Q3 2019

Nov 15, 2019

SELL
$14.16 - $25.34 $1.93 Million - $3.45 Million
-136,000 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$27.0 - $30.25 $3.67 Million - $4.11 Million
136,000 New
136,000 $3.69 Million

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $165M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.